{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Batu ED"],"funding":["National Institute of Arthritis and Musculoskeletal and Skin Diseases","National Institutes of Health","NIAMS NIH HHS"],"pagination":["152289"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11089463"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["63"],"pubmed_abstract":["<h4>Objective</h4>The COVID-19 pandemic has affected patient care in general. We aimed to analyze the impact of the pandemic on pediatric rheumatology practice.<h4>Methods</h4>An online survey including 22 questions was created by the representatives of the Emerging RheumatoloGists and rEsearchers (EMERGE) group of the Pediatric Rheumatology European Society (PReS) on SurveyMonkey. The descriptive analysis of the responses was performed on SurveyMonkey.<h4>Results</h4>Overall, 469 pediatric rheumatologists (F/M: 2.9) from 70 countries completed the survey. The practice of drug prescription is not affected by the pandemic, according to 65.3 % of the respondents, while 24.3 % and 16.5 % are prescribing biologic drugs and corticosteroids less often, respectively. Over 40 % of the respondents "],"journal":["Seminars in arthritis and rheumatism"],"pubmed_title":["The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study."],"pmcid":["PMC11089463"],"funding_grant_id":["K23AR081409","K23 AR081409"],"pubmed_authors":["Demirkan FG","Faleye A","Sag E","Swart JF","Batu ED","Gmuca S","Lamot L","Uziel Y","Marrani E","Ziv A","Ardalan K"],"additional_accession":[]},"is_claimable":false,"name":"The impact of the COVID-19 pandemic on pediatric rheumatology practice: an international, cross-sectional survey study.","description":"<h4>Objective</h4>The COVID-19 pandemic has affected patient care in general. We aimed to analyze the impact of the pandemic on pediatric rheumatology practice.<h4>Methods</h4>An online survey including 22 questions was created by the representatives of the Emerging RheumatoloGists and rEsearchers (EMERGE) group of the Pediatric Rheumatology European Society (PReS) on SurveyMonkey. The descriptive analysis of the responses was performed on SurveyMonkey.<h4>Results</h4>Overall, 469 pediatric rheumatologists (F/M: 2.9) from 70 countries completed the survey. The practice of drug prescription is not affected by the pandemic, according to 65.3 % of the respondents, while 24.3 % and 16.5 % are prescribing biologic drugs and corticosteroids less often, respectively. Over 40 % of the respondents ","dates":{"release":"2023-01-01T00:00:00Z","publication":"2023 Dec","modification":"2025-04-18T16:00:19.897Z","creation":"2025-04-07T02:59:09.297Z"},"accession":"S-EPMC11089463","cross_references":{"pubmed":["37918050"],"doi":["10.1016/j.semarthrit.2023.152289"]}}